
Menelusuri Terapi Baru untuk Kanker Kolangiokarsinoma Lanjut
Cholangiocarcinoma presents significant treatment challenges, with limited options after initial therapies fail. The EA2187 trial tested Pevonedistat, revealing a lack of effective responses. The results showed safety issues and indicated …
Menelusuri Terapi Baru untuk Kanker Kolangiokarsinoma Lanjut Read More